Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis.

Arta KarruliSerenella SpieziaFilomena BocciaMassimo GagliardiFabian PataunerAnna SalemmeCiro MaielloRosa Zampino Emanuele Durante-Mangoni

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2021)

Our data suggest that maintaining immune suppression might be safe in SOTR with moderate and severe COVID-19. Specifically, receiving tacrolimus could be beneficial for COVID-19 SOTR. Because of the quality of the available evidence, no definitive guidance on how to manage SOTR with COVID-19 can be derived from our data.

Keyphrases

coronavirus disease
sars cov
electronic health record
big data
squamous cell carcinoma
deep learning
locally advanced
drug induced